Uncategorized

Sobi Q3 2025 report: Accelerated growth and portfolio momentum

PR Newswire
By PR Newswire
1 Min Read
Fallback image

STOCKHOLM, Oct. 20, 2025 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter 2025 Third Quarter 2025 Total revenue increased 13 per cent, 21 per cent at constant exchange rates, (CER)1, to SEK 7,776 M (6,894) Haematology revenue…

​STOCKHOLM, Oct. 20, 2025 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter 2025 Third Quarter 2025 Total revenue increased 13 per cent, 21 per cent at constant exchange rates, (CER)1, to SEK 7,776 M (6,894) Haematology revenue…  ​All Consumer Technology

Share This Article
ByPR Newswire
PR Newswire is the storytelling engine behind thousands of corporate announcements worldwide. With a rich legacy in media distribution, it helps brands turn their updates into meaningful narratives by connecting them with journalists, investors, and audiences who shape global conversations. Through trusted networks and data-backed distribution, PR Newswire ensures every story reaches the people who matter most.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *